Pfizer Inc
PFE- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000078003
No open-market purchases or sales by Pfizer Inc insiders were filed in the last 90 days; 2,858 institutions reported holding it in 13F filings for Q2 2026, worth $91.9B in total; Fairfax Financial is the only superinvestor holding it.
Key figures
- Market capClose on Nov 9, 2026
- $166.6B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −82 vs. previous quarter
- 2,858
- 13F valueReported value at the end of Q2 2026
- $91.9B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $62.6B
- −1.6% year over year
- Net income, FY2025
- $7.77B
- −3.2% year over year
- Free cash flow, FY2025
- $9.07B
- −7.7% year over year
- Revenue, Q3 FY2026
- $16.6B
- −0.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 137.8M
- Shares sold short
- Change
- −12.4M
- −8.3% vs. previous
- Days to cover
- 4.47
- At average daily volume
Superinvestors holding PFE, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Pfizer Inc on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Pfizer Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 (view filing)4:04 PM ET | Aug 12 | Same day | Bourla AlbertChairman & CEO | PPurchase | +38.0K | $26.34 | +$1.00M | +9.7%429.2K after | |
| Aug 6, 2026 (view filing)11:26 AM ET | Aug 5 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −3.28K | $25.40 | −$83.3K | −10.3%28.6K after | |
| Aug 5, 2026 (view filing)4:03 PM ET | Aug 5 | Same day | Blaylock Ronald EDirector | PPurchase | +39.2K | $25.46 | +$998.8K | +141.6%66.9K after | |
| Aug 5, 2026 (view filing)4:02 PM ET | Aug 5 | Same day | Buckley Mortimer JDirector | PPurchase | +37.6K | $25.52 | +$960.4K | New position37.6K after | |
| Jun 10, 2026 (view filing) | Jun 9 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −2.00K | $25.70 | −$51.4K | −6.0%31.4K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Damico Jennifer B.SVP & Controller | SSale | −2.50K | $25.93 | −$64.8K | −17.4%11.8K after | |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Blaylock Ronald EDirector | PPurchase | +19.5K | $25.65 | +$499.1K | +235.8%27.7K after | |
| Oct 31, 2024 (view filing) | Oct 30 | 1 day | Gottlieb ScottDirector | PPurchase | +1.00K | $28.24 | +$28.2K | +11.1%10.0K after | |
| Aug 14, 2024 (view filing) | Aug 13 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −5.15K | $28.66 | −$147.7K | −37.5%8.58K after | |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Gottlieb ScottDirector | PPurchase | +3.00K | $26.47 | +$79.4K | +50.0%9.00K after |
Top 10 13F holders, Q2 2026
See all 2,858 holdersThe largest institutional positions in Pfizer Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 529,670,433 | $12.8B | 0.19% | +31,412,883+6.3% | Added |
| Vanguard Capital Management LLC | 372,149,852 | $8.96B | 0.19% | +2,719,840+0.7% | Added |
| State Street Corp | 307,090,897 | $7.39B | 0.22% | +5,501,032+1.8% | Added |
| Geode Capital Management, LLC | 135,275,782 | $3.25B | 0.17% | +1,714,040+1.3% | Added |
| Vanguard Portfolio Management LLC | 119,235,030 | $2.87B | 0.13% | +2,500,335+2.1% | Added |
| Fisher Asset Management, LLC | 109,067,291 | $2.63B | 0.78% | +4,102,864+3.9% | Added |
| Morgan Stanley | 96,345,452 | $2.32B | 0.12% | +3,660,082+3.9% | Added |
| Norges Bank | 61,505,586 | $1.48B | 0.15% | +61,505,586 | New |
| Northern Trust Corp | 59,084,573 | $1.42B | 0.17% | −2,941,979−4.7% | Reduced |
| Bank of New York Mellon Corp | 57,879,546 | $1.39B | 0.23% | +3,999,646+7.4% | Added |
Holders of 5% or more of PFE
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Pfizer Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 7.51%427.4M shares | New | May 1, 20261 filing | May 1, 2026 | SEC |
Politician trades
All politician trades in PFE50 members of Congress reported 137 trades in Pfizer Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 13, 2026 |  Carol D. Miller House · WV | Sell | $15K-$50K |
| Aug 7, 2026 |  Michael A. Rulli House · OH | Sell | $1K-$15K |
| Aug 5, 2026 |  Tommy Tuberville Senate · AL | Sell (full) | $15K-$50K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Sell (full) | $50K-$100K |
| Jul 16, 2026 | Tommy Tuberville Senate · AL | Sell (full) | $15K-$50K |
House · WV · Aug 13, 2026
Sell$15K-$50K
House · OH · Aug 7, 2026
Sell$1K-$15K
Senate · AL · Aug 5, 2026
Sell (full)$15K-$50K
Senate · OK · Jul 21, 2026
Sell (full)$50K-$100K
Senate · AL · Jul 16, 2026
Sell (full)$15K-$50K